Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1436 participants.
Also called NCT05846893
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,436 participants
- Sponsor
- Registry
-
NCT05846893
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Malaysia, Singapore, South Korea, Taiwan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05846893. Randomized; no masking; primary purpose treatment. Start 2023-09-07 (actual); primary completion 2027-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
- Acronym
- REVERSE
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Ischemia
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Stenosis
- Condition
- De Novo Stenosis
- Intervention (Device)
- SeQuent® Please NEO drug-coated balloon catheter
- Intervention (Device)
- Current-generation drug-eluting stent
- Lead sponsor
- B. Braun Medical Industries Sdn. Bhd.
- Collaborator
- B. Braun Melsungen AG
- Collaborator
- Ulsan University Hospital
- Collaborator
- European Cardiovascular Research Center
- Collaborator
- Seoul National University Hospital
- Collaborator
- Universität des Saarlandes
Record details
- Record id
cardio:ct-nct05846893- Content hash
fdcba0b17acb9dfaebcda4c539cdeeb75e585e6da7c1de133d2c781cfd5fd286